Alternative Targets for Modulators of Mitochondrial Potassium Channels

Antoni Wrzosek1, Shur Gałecka1, Monika Żochowska1

  • 1Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.

Insights

Mitochondrial potassium channels are key regulators of cell function and survival. Modulating these channels offers potential therapeutic strategies for ischemia/reperfusion injury and cancer, despite challenges with compound specificity.

Area of Science:

  • Cellular Biology
  • Pharmacology
  • Mitochondrial Physiology

Background:

  • Mitochondrial potassium channels regulate critical cellular processes including membrane potential, respiration, and reactive oxygen species (ROS) production.
  • Pharmacological activation of these channels during ischemia/reperfusion (I/R) injury promotes cell survival via cytoprotective mechanisms.
  • Inhibition of mitochondrial potassium channels induces cell death in cancer cells, highlighting their therapeutic potential.

Purpose of the Study:

  • To review the various classes of mitochondrial potassium (mitoK) channels.
  • To describe chemical compounds that modulate mitoK channel activity.
  • To discuss the multidirectional effects of mitoK channel modulators.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of chemical compounds targeting mitochondrial potassium channels.
  • Examination of experimental data on channel activators and inhibitors.

Main Results:

  • Mitochondrial potassium channels play a dual role in cell survival and death depending on the context.
  • Activators show cytoprotective effects in I/R injury, while inhibitors are effective against cancer cells.
  • Many modulators exhibit off-target effects, complicating their therapeutic application.

Conclusions:

  • Mitochondrial potassium channels are promising therapeutic targets for I/R injury and cancer.
  • Development of specific mitoK channel modulators is crucial to avoid unwanted side effects.
  • Further research is needed to fully elucidate the complex roles and therapeutic potential of these channels.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
333
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.3K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.8K